胞浆型磷脂酶A2(PLA2G4)单克隆抗体

Monoclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4)

c-PLA2; cPLA2; PLA2G4A; Phospholipase A2, Cytosolic; Phospholipase A2,Group IV(Cytosolic,Calcium-Dependent); Phosphatidylcholine 2-acylhydrolase; Lysophospholipase

  • 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 产品包装(模拟)
  • 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 产品包装(模拟)
  • 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 DAB staining on IHC-P; Sample: Human Breast cancer Tissue Primary Ab: 30µg/ml Mouse Anti-Human PLA2G4 Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 DAB staining on IHC-P;
    Sample: Human Liver Tissue
    Primary Ab: 30µg/ml Mouse Anti-Human PLA2G4 Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 DAB staining on IHC-P;
    Sample: Human Kidney Tissue
    Primary Ab: 30µg/ml Mouse Anti-Human PLA2G4 Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 DAB staining on IHC-P;
    Sample: Human Pancreas Tissue
    Primary Ab: 30µg/ml Mouse Anti-Human PLA2G4 Antibody
    Control: Used PBS instead of primary antibody
    Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对PLA2G4的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别PLA2G4。

用法

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Homo sapiens (Human，人) 应用(仅供研究使用，不用于临床诊断！)
RPB624Hu02 胞浆型磷脂酶A2(PLA2G4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB624Hu01 胞浆型磷脂酶A2(PLA2G4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB624Hu01 胞浆型磷脂酶A2(PLA2G4)多克隆抗体 WB,IHC
PAB624Hu02 胞浆型磷脂酶A2(PLA2G4)多克隆抗体 WB,IHC
LAB624Hu71 胞浆型磷脂酶A2(PLA2G4)多克隆抗体(生物素标记) WB; IHC; ICC.
MAB624Hu21 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 WB,IHC
MAB624Hu22 胞浆型磷脂酶A2(PLA2G4)单克隆抗体 WB; IHC; ICC; IP.
FAB624Hu02 抗胞浆型磷脂酶A2(PLA2G4)单克隆抗体 FCM
FAB624Hu04 抗胞浆型磷脂酶A2(PLA2G4)单克隆抗体 FCM
FAB624Hu06 抗胞浆型磷脂酶A2(PLA2G4)单克隆抗体 FCM

参考文献

杂志 参考文献
BIOMEDICINE & PHARMACOTHERAPY The synergistic mechanism of total saponins and flavonoids in Notoginseng− Safflower pair against myocardial ischemia uncovered by an integrated … [Pubmed: 32739736]
留言咨询